-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, QfnucsQPLJ69bYh5HvKlwfi/fVMxMuOOw6uia+zjunoRYz8UtKPzgTOwwaI9e6/r qpzkRAopCJ1s3FOiMYdrxQ== 0001247741-06-000017.txt : 20061121 0001247741-06-000017.hdr.sgml : 20061121 20061121183843 ACCESSION NUMBER: 0001247741-06-000017 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20061117 FILED AS OF DATE: 20061121 DATE AS OF CHANGE: 20061121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LIGAND PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000886163 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 770160744 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10275 SCIENCE CENTER DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121-1117 BUSINESS PHONE: 8585507500 MAIL ADDRESS: STREET 1: 10275 SCIENCE CENTER DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121-1117 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BROADDUS WARNER R CENTRAL INDEX KEY: 0001182610 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33093 FILM NUMBER: 061233975 BUSINESS ADDRESS: BUSINESS PHONE: 8585507577 MAIL ADDRESS: STREET 1: C/O LIGAND PHARMACEUTICALS INC., STREET 2: 10275 SCIENCE CENTER DR. CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 edgardoc.xml PRIMARY DOCUMENT X0202 4 2006-11-17 0 0000886163 LIGAND PHARMACEUTICALS INC LGND 0001182610 BROADDUS WARNER R 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121 0 1 0 0 V-P, Gen. Counsel & Secy. Common Stock 2006-11-17 4 M 0 5476 7.25 A 9122 D Common Stock 2006-11-17 4 S 0 5476 11.35 D 3646 D Common Stock 2006-11-17 4 M 0 1191 7.25 A 4837 D Common Stock 2006-11-17 4 S 0 1191 11.35 D 3646 D Common Stock 2006-11-17 4 M 0 5208 9.25 A 8854 D Common Stock 2006-11-17 4 S 0 5208 11.4 D 3646 D Common Stock 2006-11-17 4 M 0 16667 9.25 A 20313 D Common Stock 2006-11-17 4 S 0 1918 11.4 D 18395 D Common Stock 2006-11-17 4 S 0 459 11.35 D 17936 D Common Stock 2006-11-17 4 S 0 4464 11.31 D 13472 D Common Stock 2006-11-17 4 S 0 2700 11.3201 D 10772 D Common Stock 2006-11-17 4 S 0 289 11.3 D 10483 D Common Stock 2006-11-17 4 S 0 1100 11.32 D 9383 D Common Stock 2006-11-17 4 S 0 1311 11.33 D 8072 D Common Stock 2006-11-17 4 S 0 4426 11.3301 D 3646 D Common Stock 2006-11-20 4 S 0 2000 11.4801 D 1646 D Common Stock 2006-11-20 4 S 0 1646 11.48 D 0 D Employee Stock Option (right to buy) 7.25 2006-11-17 4 M 0 5476 0 D 2006-01-05 2015-07-05 Common Stock 5476 14524 D Employee Stock Option (right to buy) 7.25 2006-11-17 4 M 0 1191 0 D 2006-01-05 2015-07-05 Common Stock 1191 13333 D Employee Stock Option (right to buy) 9.25 2006-11-17 4 M 0 5208 0 D 2013-04-29 Common Stock 5208 19792 D Employee Stock Option (right to buy) 9.25 2006-11-17 4 M 0 16667 0 D 2013-04-29 Common Stock 16667 3125 D Grant to reporting person of options, exercisable over a 4-year period measured from the date of grant, 12-1/2% after six months, then 1/48th of the Option Shares per month thereafter. The date of grant is 7/5/05. Grant to reporting person of options, exercisable over a 4-year period measured from the date of grant, 12-1/2% after six months, then 1/48th of the Option Shares per month thereafter. The date of grant is 4/29/03. The Amount of Securities Beneficially Owned prior to the transactions reported on this Form 4 includes 1,218 shares acquired under the Ligand employee stock purchase plan between 6/30/04 and 3/31/05. By: Barbara J. Olson For: Warner Broaddus 2006-11-21 -----END PRIVACY-ENHANCED MESSAGE-----